GLP-1 side effects and weight loss claims: what's real

What did @genarutledge76 actually say?

The creator was responding to a viewer named Erica who had just taken her first dose of Ozempic. The video is warm and encouraging, which is fine, but it contains a few medical claims worth unpacking. She said the medicine "should make you feel more full" and help you stop "wanting to eat all day." She also shared her personal experience that she "probably lost the most weight on point two five" — referring to the 0.25mg starting dose — and advised Erica that the drug "may take a couple days" to kick in. These are not throwaway comments. They're framed as guidance for someone who is brand new to a GLP-1 medication.

To be fair, the creator isn't presenting herself as a clinician. She's a patient sharing her experience. But with 4.8K views and a direct reply to someone who literally just took their first injection, the stakes of getting this wrong are real.

Does the science back this up?

Partially. The satiety mechanism is well-documented, but the claim about losing the most weight on the lowest dose is not how semaglutide typically works in clinical trials. The timing claim is also more complicated than "a couple days."

Semaglutide works primarily by activating GLP-1 receptors in the hypothalamus and gut, slowing gastric emptying and reducing appetite. That part — feeling more full — is solid. Wilding et al. (2021, NEJM) confirmed in the STEP 1 trial that semaglutide 2.4mg weekly produced significant weight loss compared to placebo, largely driven by reduced caloric intake from appetite suppression. The drug does make you feel fuller. Credit where it's due.

But the dose-response relationship in semaglutide is cumulative. The 0.25mg dose is a titration dose, not a therapeutic dose. Rubino et al. (2021, JAMA) found that discontinuing semaglutide was associated with weight regain, which suggests the therapeutic effect builds over time and at higher doses — not that lower doses work best.

What did they get wrong (or right)?

The satiety claim is right. The weight loss timing claim is the problem. The creator said she "probably lost the most weight on point two five." This could be true for her individually — early dietary restriction, novelty effect, anxiety-driven appetite suppression — but presenting it as a meaningful data point to a new patient is misleading without serious caveats.

The 0.25mg dose is explicitly a four-week ramp-up dose in Novo Nordisk's prescribing information. It exists to reduce gastrointestinal side effects, not to maximize weight loss. Clinical weight loss with semaglutide typically accelerates as doses increase. Presenting the lowest dose as the most effective could discourage appropriate titration or create false expectations when Erica doesn't lose much at 0.25mg.

The "couple of days" timeline is also shaky. Semaglutide has a half-life of approximately one week. Full steady-state plasma concentration takes roughly four to five weeks. Some patients feel appetite changes quickly; many don't. Davies et al. (2021, Lancet) found meaningful appetite reduction emerged over weeks, not days, in most participants.

What should you actually know?

If you're starting Ozempic or any semaglutide product, here is what the evidence actually says. First, the 0.25mg starting dose is about tolerability, not efficacy. Do not judge the drug's effectiveness during this phase. Second, appetite suppression is real and well-supported, but individual response varies significantly. Third, the drug needs weeks, not days, to reach steady state. Some people feel changes in week one; others don't notice much until week four or later.

The creator's broader message — that everyone is different, that side effects vary, that you should give it time — is genuinely good advice. But mixing that reasonable framing with the specific personal claim about losing the most weight on the lowest dose muddles the picture for a new patient. If Erica doesn't lose weight on 0.25mg, she now has a data point from a TikTok creator suggesting that's the best dose. That's a problem. Anyone starting a GLP-1 medication should be getting their expectations set by a prescriber, not a comment section.